TIM
LUCD icon

Thompson Investment Management’s Lucid Diagnostics LUCD Stock Holding History

Thompson Investment Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$1 – 517
2024
Q3 		$1 Hold
1
– – ﹤0.01% 502
2024
Q2 		$1 Hold
1
– – ﹤0.01% 502
2024
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 522

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Thompson Investment Management's LUCD Position: Q4 2024 in Review

Thompson Investment Management sold out of Lucid Diagnostics (LUCD) in Q4 2024, closing a stake of 1 share — an estimated $1 sold.

Thompson Investment Management first reported a position in LUCD in Q1 2024 and held it in 3 quarters. The position peaked at $1 in Q3 2024. 33 funds tracked by Wall St. Rank hold LUCD as of Q4 2024.

  • Thompson Investment Management reported no remaining Lucid Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Thompson Investment Management sold 1 Lucid Diagnostics share in Q4 2024, an estimated $1.
  • Thompson Investment Management first reported a position in Lucid Diagnostics in Q1 2024 and held it in 3 quarters.
  • Thompson Investment Management's Lucid Diagnostics position peaked at $1 in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q4 2024.

Based on Thompson Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.